<strong>Value of Neuroimaging in Vascular Cognitive Impairment</strong>

Abstract

Abstract:

Vascular cognitive impairment （VCI） is a cognitive spectrum disease，caused by risk factors of cerebrovascular diseases （hypertension，diabetes，hyperlipidemia），and obvious cerebrovascular diseases （such as cerebral infarction，cerebral hemorrhage） or less obvious cerebrovascular diseases （such as loose white matter，chronic cerebral ischemia）. It encompasses the full range of cognitive defcits from mild cognitive impairment to dementia. Since clinical signs and symptoms are often neither sufficient to allow for a final diagnosis，nor differentiate among the various etiologies，however neuroimaging can display the visualization of ischemic and hemorrhagic injury of gray and white matter，which not only plays an important role in the diagnosis of patients with impaired cognition，but also explore the pathophysiology of VCI. This review summarizes the application of neuroimaging methods in VCI diagnosis nowdays，including computed tomography （CT），high resolution magnetic resonance imaging（HRMRI），diffusion tensor imaging （DTI），magnetic resonance imaging spectroscopy （MRS），and dynamic contrastenhanced MRI （DCEMRI） and blood oxygen level dependent functional magnetic resonance imaging （BOLD-fMRI）.

Key words:vascular cognitive impairment,neuroimaging,magnetic resonance imaging,positron emission tomography

CLC Number:

R964

Cite this article

BAI Yan-chang，JIA Yan-li，WANG Jian-hua.Value of Neuroimaging in Vascular Cognitive Impairment[J]. Acta Neuropharmacologica,DOI: 10.3969/j.issn.2095-1396.2017.06.001.

share this article

0
/Recommend

Add to citation managerEndNote|Ris|BibTeX

URL:http://actanp.hebeinu.edu.cn/EN/10.3969/j.issn.2095-1396.2017.06.001

http://actanp.hebeinu.edu.cn/EN/Y2017/V7/I6/1

References

[1]Tgeodore P Zanto, Judy Pa, Adam Gazzaley.Reliability measures of functional magnetic resonance imaging in a longitudinal evaluation of mild cognitive impairment[J].Neuroimage, 2014, 84: 443-452.

[2]Hampstead B M, Mohammad Khoshnoodi, Yan Wen-jing,et al.Patterns of effective connectivity during memory encoding and retrieval differ between patients with mild cognitive impairment and healthy older adults[J].Neuroimage, 2016, 124(Pt A): 997-1008

[3]Li Chuan-ming, Zheng J ian,Wang Jian,et al.An fMRI stroop task study of prefrontal cortical function in normal aging, mild cognitive impairment, and Alzheimer's disease[J].Curr Alzheimer Res, 2009, 6(6): 525-530.

[4]Christppher A Hostage, Kingshuk Roy Choudhury, PMurali Doraiswamy,et al.Mapping the effect of the apolipoprotein E genotype on 4-year atrophy rates in an Alzheimer disease-related brain network[J].Radiology, 2014, 271(1): 211-219.

[5]Albert C Yang, Chu-Chung Huang, Liu Mu-En,et al.The APOE ?4 allele affects complexity and functional connectivity of resting brain activity in healthy adults[J].Hum Brain Mapp, 2014, 35(7): 3238-3248.

[6]唐梅丽,陈鑫,陈志远,等.肌萎缩侧索硬化症在3.0TMR及弥散张量纤维束示踪技术上的表现[J].暨南大学学报:自然科学与医学版, 2014, 35(6):555-560.

[7]Ana FilipaGeraldo, Lise-PruneBerner, JulieHaesebaert,et al.Does b1000-b0 mismatch challenge diffusion-weighted imaging-fluid attenuated inversion recovery mismatch in stroke?[J].Stroke, 2016, 47(3):877-881.

[8]Michaela Defrancesco, Egger Karl, Josef Marksteiner,et al.Changes in white matter integrity before conversion from mild cognitive impairment to Alzheimer's disease[J]. PLoS One 2014, 9(8):e106062.

[9]Zhang Yu, Nobert Schuff, Monica Camacho,et al.MRI markers for mild cognitive impairment: comparisons between white matter integrity and gray matter volume measurements[J]. PLoS One, 2013, (6):e66367.

[10]Lerner A,Mogensen M A,Kim P E,et al.Clinical applications of diffusion tensor imaging[J]. World Neurosurg, 2014, 82(1-2):96-109

[11]Wang Jian-hua, Lv Pei-yuan, Wang He-bo,et al.Diffusion tensor imaging measures of normal appearing white matter in patients who are aging, or have amnestic mild cognitive impairment, or Alzheimer's disease[J]. J ClinNeurosci, 2013, 20(8):1089-1094.

[12]Yawu Liu, Gabriela Spulber, Kimmo K Lehtimäki,et al.Diffusion tensor imaging and tract-based spatial statistics in Alzheimer's disease and mild cognitive impairment[J].Neurobiol Aging, 2011, 32(9): 1558-1571.

[13]Olivier Naggara, Catherine Oppenheim, Dorothee Rieu,et al.Diffusion tensor imaging in early Alzheimer's disease[J]. Psychiatry Res, 2006, 146(3): 243-249.

[14]Po H Lu, Grace J Lee, Jill Shapira,et al.Regional differences in white matter breakdown between frontotemporal dementia and early-onsetAlzheimer's disease[J]. J Alzheimers Dis, 2014, 39(2):261-269

[15]Min-Chien Tu, Chung-Ping Lo, Ching-Feng Huang,et al.Effectiveness of diffusion tensor imaging in differentiating early-stage subcortical ischemic vascular disease, Alzheimer's disease and normal ageing[J]. PLoS One, 2017, 12(4):e0175143.

[16]Kejal Kantarci.Fractional anisotropy of the fornix and hippocampal atrophy in Alzheimer's disease[J]. Front Aging Neurosci, 2014, 13(6):316.

[17]Milap A Nowrangi, Constantine G Lyketsos, Jeannie-Marie S Leoutsakos,et al.Longitudinal, region-specific course of diffusion tensor imaging measures in mild cognitive impairment and Alzheimer's disease[J]. Alzheimers Dement, 2013, 9(5):519-528.

[18]Heidi IL Jacobs, Martin P J van Boxtel, Ed H B M Gronenschild,et al.Decreased gray matter diffusivity: a potential early Alzheimer's disease biomarker? [J]. Alzheimers Dement, 2013, 9(1):93-97.

[19]李香春,刘江红,王海平,等.弥散张量成像对遗忘型轻度认知障碍诊断和预后评估的价值[J].中国全科医学,2016, 19(11): 1282-1286.

[20]陈旭高,邹建勋,王明杰,等. 3.0T磁共振ASL及MRS技术在阿尔茨海默病的应用研究[J].医学影像学杂志, 2015, 25(1):14-17.

[21]Maja A A Binnewijzend, Joost P A Kuijer, Marije Benedictus,et al.Cerebral blood flow measured with 3D pseudocontinuous arterial spin-labeling MR imaging in Alzheimer disease and mild cognitive impairment: a marker for disease severity[J]. Radiology, 2013, 267(1):221-230.

[22]Simonsen C Z, Madsen M H, Schmitz M L,et al. Sensitivity of diffusion- and perfusion-weighted imaging for diagnosing acute ischemic stroke is 97.5% [J].Stroke, 2015, 46(1): 98-101.

[23]Aikaterini Xekardaki, Cristelle Rodriguez, Marie-Louise Montandon,et al.Arterial spin labeling may contribute to the prediction of cognitive deterioration in healthy elderly individuals[J]. Radiology, 2015, 274(2):490-499.

[24]Zou Jian-Xun, Wang Ming-Jie, Lei Xin-Jun,et al.3.0 T MRI arterial spin labeling and magnetic resonance spectroscopy technology in the application of Alzheimer's disease[J]. ExpGerontol, 2014, 60:31-36.

[25]Zhang Bing, Tanis J Ferman, Bradley F Boeve,et al.MRS in mild cognitive impairment: early differentiation of dementia with Lewy bodies and Alzheimer's disease[J]. J Neuroimaging, 2015, 25(2):269-274

[26]Huang Dan-dan,Liu Dan,Yin Jian-zhong,et al.Erratum to: Glutamate-glutamine and GABA in brain of normal aged and patients with cognitive impairment[J]. EurRadiol, 2017, 27(7):2706-2707.

[27]Fayed N, Modrego P J, García-Martí G,et al.Magnetic resonance spectroscopy and brain volumetry in mild cognitive impairment. A prospective study[J]. MagnReson Imaging, 2017, 38:27-32.

[28]Wang Hui, Tan Lan, Wang Hui-Fu,et al.Magnetic Resonance Spectroscopy in Alzheimer's Disease: Systematic Review and Meta-Analysis[J]. J Alzheimers Dis, 2015, 46(4):1049-1070.

[29]Wolfgang Grodd, Beckmann C F.Resting state functional MRI of the brain[J]. Nervenarzt, 2014, 85(6): 690-700.

[30]Stavros Dimitriadis.Quantifying the predictive power of resting-state functional connectivity (rs-fc) fMRI for identifying patients with Alzheimer's disease (AD)[J]. ClinNeurophysiol, 2015, 126(11): 2043-2044.

[31]Edward Challis, Peter Hurley, Laura Serra,et al.Gaussian process classification of Alzheimer's disease and mild cognitive impairment from resting-state fMRI[J]. Neuroimage, 2015, 15(112):232-243.

[32]Stefan J Teipel, Alexandra Wohlert, Coraline Metzger,et al.Multicenter stability of resting state fMRI in the detection of Alzheimer's disease and amnestic MCI[J]. Neuroimage Clin, 2017, 18(14):183-194.

[33]Wang Yu-mei, Zhao Xiao-chuan, Xu Shun-jiang,et al.Using regional homogeneity to reveal altered spontaneous activity in patients with mild cognitive impairment[J]. Biomed Res Int, 2015, 2015:807093.

[34]Bin-ke Yuan, Wang Jue, Zang Yu-feng,et al．Amplitude differences in high-frequency fMRI signals between eyes open and eyes closed resting states[J]. Front Hum Neurosci, 2014, 8:503.

[35]Han Ying, Wang Jin-hui, Zhao Zhi-lian,et al.Frequency-dependent changes in the amplitude of low-frequency fluctuations in amnestic mild cognitive impairment: a resting-state fMRI study[J]. Neuroimage, 2011, 55(1):287-295．

[36]周波,张增强,安宁豫,等.轻度认知障碍患者丘脑功能连接的随访研究[J].临床和实验医学杂志,2014,13(10): 784-788.

[37]姚洪祥,安宁豫,张熙,等.遗忘型轻度认知障碍杏仁核功能连接静息态纵向变化功能磁共振研究[J].放射学实践, 2014, 29, (6); 613-617．

[38]盛灿,夏明睿,陈晓丹,等.遗忘型轻度认知障碍患者的静息态功能连接强度特征研究[J].中华放射学杂志, 2016, 50(3): 191-195.

[39]席芊,赵小虎,王培军,等．遗忘型轻度认知损害患者基于低频振幅的静息态功能磁共振成像研究[J].上海交通大学学报, 2014, 34(8):1162-1166.

[40]Wang Yan, Chen Ke-wei, Yao Li,et al.Structural interactions within the default mode network identified by Bayesian network analysis in Alzheimer's disease[J]. PLoS One, 2013, 8(8):e74070.

Metrics

Viewed

Full text

Abstract

Abstract
References
Related Articles
Recommended Articles
Metrics

TOP

Value of Neuroimaging in Vascular Cognitive Impairment

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles5

Recommended Articles

Metrics

[1]	YUAN Yong-gui.A Study of Diagnosis and Early Efficacy Prediction Biomarkers for Major Depressive Disorder[J]. Acta Neuropharmacologica, 2018, 8(4): 42-44.
[2]	BAI Yan-chang，JIA Yan-li，SONG Ya-xue，WANG Jian-hua.Advance of Functional Magnetic Resonance Imaging of Brain in Alzheimer’s Disease[J]. Acta Neuropharmacologica, 2017, 7(3): 6-11.
[3]	FENG Hui-li,WANG Peng-wen .[J]. Acta Neuropharmacologica, 2016, 6(3): 24-31.
[4]	WU Peng1, LU Guo-shi2, HAN Feng2, XU Ke-ning2, WANG Hai-chen2.The Experimental Study of Susceptibility Weighted Imaging and Diffusion Weighted Imaging in the Blast Injury to the Rabbits Brain at 3.0T MRI[J]. Acta Neuropharmacologica, 2012, 2(2): 21-28.
[5]	Deng Liang, Shi Yi-Kai, Zhang Jun-Tian .High Temporal-spatial Resolution Neuroimaging Method Based on Reconstruction of MRI Scan Data with Optic-sensing Temporal Calibration[J]. Acta Neuropharmacologica, 2011, 1(3): 47-54.